Quality CareFind out why Mayo Clinic is the right place for your health care. Make an appointment.
Meet the StaffFind a directory of doctors and departments at all Mayo Clinic campuses. Visit now.
Research and Clinical TrialsSee how Mayo Clinic research and clinical trials advance the science of medicine and improve patient care. Explore now.
Visit Our SchoolsEducators at Mayo Clinic train tomorrow’s leaders to deliver compassionate, high-value, safe patient care. Choose a degree.
Professional ServicesExplore Mayo Clinic’s many resources and see jobs available for medical professionals. Get updates.
Give to Mayo ClinicHelp set a new world standard in care for people everywhere. Give now.
This project's findings are likely to lead to an effective monocyte-directed therapeutic approach for patients with lymphoma.
This project is designed to explore a novel approach to in situ immunization that could represent a novel approach to therapy for lymphoma and other cancers.
This project explores mechanisms of JAK/STAT pathway activation and a new JAK2 kinase inhibitor in a clinical trial for relapsed lymphoma.
As the first comprehensive study of both germline and somatic genetic variants in diffuse large B-cell lymphoma, this project provides new insights into lymphomagenesis.
Mayo Clinic is a not-for-profit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.